Press release
Biopharmaceutical Excipient Manufacturing Market: Trends, Applications, and Growth Forecast 2024-2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biopharmaceutical Excipient Manufacturing Market- by Type of Biologics (Antibodies, Vaccines, Cell Therapies and Other Biologics), Type of Excipient (Carbohydrates, Polymers, Solubilizers/Surfactants, Polyols, Proteins/Amino Acids and Others), Scale of Operation (Preclinical, Clinical and Commercial), Trends, Industry Competition Analysis, Revenue and Forecast To 2030."
Get a free sample copy of the report: https://www.insightaceanalytic.com/request-sample/1197
According to the latest research by InsightAce Analytic, the global Biopharmaceutical Excipient Manufacturing market will be valued at US$ 1.15 Billion in 2021. It is expected to reach US$ 2.62 Billion by 2030, with a CAGR of 9.7% during a forecast period of 2024-2031.
Carrier materials known as excipients are helpful when creating biopharmaceuticals. They change the solubility of APIs, enhance medication stability in the dosage form, and offer efficient ingredient binding. Inert, reproducible excipients can be made from minerals, sugar, corn, wheat, and other ingredients. They can improve quality, boost output volume, and reduce operating costs.
Over time, the growing acceptance of biologics has led to a paradigm shift in the healthcare industry. Only in the last ten years has the US FDA progressively expanded the amount of biopharmaceuticals-including gene therapies, vaccines, recombinant proteins, and monoclonal antibodies-that it approves yearly. Today, more than eight thousand biological pharmaceutical molecules are being studied in various clinical settings worldwide.
Growing emphasis on developing novel drugs, rising rates of chronic diseases, expanding use of lipid and sucrose-based excipients, and technological advancements in pharmaceutical manufacturing all contribute to market players' efforts to create excipients for novel, high-quality drugs. The main driver of the biopharmaceutical excipient manufacturing market is the advancement of R&D activities in the pharmaceutical sector.
The expanding number of COVID cases has raised the burden of generating medications for biopharmaceutical companies to treat affected individuals. Consequently, businesses are stressing the need for rapid medication development. Excipients enhance the synthesis of biopharmaceuticals effectively and efficiently. The need for biopharmaceutical excipients to create new and stable pharmaceuticals is increasing, which will provide significant opportunities for development throughout the forecast period.
However, throughout the projected period, market expansion may be hampered by the difficulties involved in medication manufacturing and the large capital expenditure needed.
North America is anticipated to be the major contributor to the Biopharmaceutical Excipient Manufacturing market ascribed to various elements, including important players, an increase in drug research, and a sizable population base. Collaborations between businesses in this area are being used to produce biopharmaceutical excipients.
In addition, the Asia Pacific regional market is expected to register significant growth since the prevalence of chronic diseases is rising, healthcare spending is increasing, and drug demand is rising. China and India are the two developing nations in this sector.
Major market players operating in the Biopharmaceutical Excipient Manufacturing market include
ABITEC (US), Avantor (US), BASF Pharma (Germany), Corden Pharma (Germany), DFE Pharma (Germany), Evonik (Germany), Kirsch Pharma (Germany), Merck KGaA (Germany), Pfanstiehl (US), Roquette (France), Spectrum Chemical Manufacturing (US), SPI Pharma (US), and Others.
Recent collaborations and agreements in the market:
• In April 2020, DFE Pharma recently introduced a new line of biopharmaceutical excipients to stabilize biologics. The highest purity excipients that can be utilized in the formulation are included in BioHale, a new spectrum of excipients. It is currently being developed and will be sold online. It contains BioHale Sucrose and BioHale Trehalose.
Curious about this latest version of the report? Obtain Report Details @ https://www.insightaceanalytic.com/enquiry-before-buying/1197
Market Segments
Global Biopharmaceutical Excipient Manufacturing Market, by Type of Biologics, 2022-2030 (Value US$ Mn)
• Antibodies
• Vaccines
• Cell Therapies
• Other Biologics
Global Biopharmaceutical Excipient Manufacturing Market, by Type of Excipient, 2022-2030 (Value US$ Mn)
• Carbohydrates
• Polymers
• Solubilizers/Surfactants
• Polyols
• Proteins/Amino Acids
• Others
Global Biopharmaceutical Excipient Manufacturing Market, by Scale of Operation, 2022-2030 (Value US$ Mn)
• Preclinical
• Clinical
• Commercial
Global Biopharmaceutical Excipient Manufacturing Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Biopharmaceutical Excipient Manufacturing Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada
Europe Biopharmaceutical Excipient Manufacturing Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Biopharmaceutical Excipient Manufacturing Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Biopharmaceutical Excipient Manufacturing Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Biopharmaceutical Excipient Manufacturing Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa
Why should buy this report:
To receive a comprehensive analysis of the prospects for the global Biopharmaceutical Excipient Manufacturing market
To receive an industry overview and future trends of the Biopharmaceutical Excipient Manufacturing market
To analyze the Biopharmaceutical Excipient Manufacturing market drivers and challenges
To get information on the Biopharmaceutical Excipient Manufacturing market value (US$ Mn) forecast to 2030
Significant investments, mergers & acquisitions in the Biopharmaceutical Excipient Manufacturing market industry
For More Information @ https://www.insightaceanalytic.com/customisation/1197
Contact Us:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 718 593 4405
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions.
Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses.
We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products.
Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biopharmaceutical Excipient Manufacturing Market: Trends, Applications, and Growth Forecast 2024-2031 here
News-ID: 3542160 • Views: …
More Releases from InsightAce Analytic Pvt.Ltd
AI In The Credit-Scoring Market Smarter Credit Decisions: How AI is Transforming …
AI In The Credit-Scoring Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global AI In The Credit-Scoring Market - (By Component (Software and Service), By Application (Personal Credit Scoring and Corporate Credit Scoring), By Industry Vertical (BFSI (Banking, Financial Services, Insurance), Retail, Healthcare,
Telecommunications, Utilities, and Real Estate)), Trends,…
Surgical Robotics Simulation Market Guiding the Next Generation of Surgeons: Gro …
Surgical Robotics Simulation Market Worth $1,283.6 Mn by 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Surgical Robotics Simulation Market Size, Share & Trends Analysis Report By Product Type (Product, Services), By Application (General Surgery, Gynecological Surgery, Urological Surgery, Neurological Surgery (Head and Neck Surgery), Cardiological Surgery, Orthopedic Surgery, Others), By End User (Hospitals, Ambulatory Surgical Centers,…
AI Studio Market Accelerating Innovation: The Benefits of AI Studios for Busines …
Global AI Studio Market Worth $57.89 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global AI Studio Market- (By Application (Sentiment Analysis, Customer Service Automation, Image Classification & Labelling, Synthetic Data Generation, Predictive Modelling & Forecasting, Automatic Content Generation, and Others), By Offering, By Vertical, By Region, Trends, Industry Competition Analysis, Revenue and Forecast…
Human-Induced Pluripotent Stem Cells (hiPSCs) Preclinical Disease Model Market G …
Global Human-Induced Pluripotent Stem Cells (hiPSCs) Preclinical Disease Model Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Human-Induced Pluripotent Stem Cells (hiPSCs) Preclinical Disease Model Market- (Disease (Neurological Disorders and Dystrophies, Cardiac disorders, Retinal Eye Disease, Metabolic Disorders, Liver disease, Others), Products and Services (Disease Model,
Reprogramming service, Differentiation…
More Releases for Excipient
Biological Excipient Market Key Drivers for 2025
The Biological Excipient market is a crucial segment of the pharmaceutical industry, providing essential support for the efficacy and stability of drug formulations. Biological excipients are naturally derived substances that facilitate the delivery of active pharmaceutical ingredients (APIs), ensuring that medications retain their intended therapeutic effects while enhancing patient compliance and safety. The relevance of this market spans a wide range of applications, including oral and topical formulations, which cater…
Biopharmaceutical Excipient Manufacturing: Driving Efficiency in Pharmaceutical …
"Biopharmaceutical Excipient Manufacturing Market" in terms of revenue was estimated to be worth $1,372.7 Mn in 2023 and is poised to reach $2,892.5 Mn by 2031, growing at a CAGR of 9.82% from 2024 to 2031 according to a new report by InsightAce Analytic.
Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1197
Market Analysis:
Biopharmaceutical excipients serve an important role in biologic drug formulation by stabilizing, delivering, and improving the performance of active pharmaceutical…
Glucose Excipient Market Size, Players, Revenue Analysis 2023-2030
Glucose Excipient Market Overview 2023:
The Glucose Excipient Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the Glucose Excipient market. This report explores all the key factors affecting the growth of the Glucose Excipient…
Nutraceutical Excipient Market - Industry Trends and Forecast to 2028
The nutraceutical excipient market is expected to witness market growth at a rate of 7.4% in the forecast period of 2021 to 2028. Data Bridge Market Research report on nutraceutical excipient market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market's growth. The increase in the advancements in nanotechnology is escalating the growth of nutraceutical excipient…
Global Pharmaceutical Excipient Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Pharmaceutical Excipient Market is projected to grow from USD 8.6 Billion in 2022 to USD 11.5 billion in 2027 at a CAGR of 5.9% from 2022 to 2027.
The increase in demand for oral solid pharmaceutical drugs, the emergence of novel therapeutics on account of the growing number of pharmaceutical companies, the rapidly growing pharmaceuticals market, and…
Cellulose Derivative Excipient Market - Forecasts to 2026
As per the research conducted by GME, the Global Cellulose Derivative Excipient Market will grow with a CAGR value of 6.5 percent. Rapid development in the pharmaceutical & healthcare sectors, owing to an aging population and advancement in pharmaceutical technologies, has resulted in a rise in demand for drugs and medical services, positively affecting the cellulose derivative excipient market.
Browse 151 Market Data Tables and 111 Figures spread through 181 Pages…
